ADMINISTRATION PULMONAIRE DE POLYNUCLEOTIDES AGONISTES DU RECEPTEUR TOLL-LIKE 9 POUR TRAITER LE CANCER DES POUMONS

• 收藏
• 分享

专利权人:

Dynavax Technologies Corporation

发明人:

申请号：

EP16727089.1

公开号：

EP3302502B1

申请日:

2016.05.23

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

The present disclosure relates to methods for treating cancer by intrapulmonary administration of a polynucleotide Toll-like receptor 9 agonist. The methods of the present disclosure are suitable for treating primary cancer of the lung, as well as metastatic cancer to the lung and extra pulmonary cancers thereof. Additionally, the present disclosure provides polynucleotide Toll-like receptor 9 agonists with immune stimulatory and toxicity profiles suitable for intrapulmonary administration.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/